Showing results (581-590 of 601) with videos related to

Sort By:
Pageof 61
Frontiers in Pharmacology|October 5, 2018
Investigation of the HSPG2 Gene in Tardive Dyskinesia - New Data and Meta-AnalysisClement C Zai, Frankie H Lee, Arun K Tiwari, et al.
Innovations in Clinical Neuroscience|February 1, 2021
THE DEPRESSION INVENTORY DEVELOPMENT SCALE: Assessment of Psychometric Properties Using Classical and Modern Measurement Theory in a CAN-BIND TrialAnthony L Vaccarino, Amir H Kalali, Pierre Blier, et al.
Nature|April 15, 2026
Cell-type-targeted mitochondrial transplantation rescues cell degenerationTemurkhan Ayupov, Verónica Moreno-Juan, Serena Curtoni, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|June 24, 2024
Optimisation of pharmacotherapy in psychiatry through therapeutic drug monitoring, molecular brain imaging and pharmacogenetic tests: Focus on antipsychoticsXenia Marlene Hart, Gerhard Gründer, Nicolas Ansermot, et al.
Molecular Psychiatry|January 4, 2024
A primer on the use of machine learning to distil knowledge from data in biological psychiatryThomas P Quinn, Jonathan L Hess, Victoria S Marshe, et al.
Atmospheric Chemistry and Physics|September 24, 2024
A renewed rise in global HCFC-141b emissions between 2017-2021Luke M Western, Alison L Redington, Alistair J Manning, et al.
Clinical Pharmacology and Therapeutics|January 22, 2023
ABCB1 Gene Variants and Antidepressant Treatment Outcomes: A Systematic Review and Meta-Analysis Including Results from the CAN-BIND-1 StudyLeen Magarbeh, Claudia Hassel, Maximilian Choi, et al.
Journal of Psychiatry & Neuroscience : JPN|March 7, 2019
The Canadian Biomarker Integration Network in Depression (CAN-BIND): magnetic resonance imaging protocolsGlenda M. MacQueen, Stefanie Hassel, Stephen R. Arnott, et al.
Pageof 61